Glenmark Pharmaceuticals to launch Brukinsa (zanubrutinib) in India after DCGI approval, offering treatment for five B-cell blood cancers with fewer cardiac side effects and flexible dosing options.

Glenmark shares on Monday ended 0.68% up at ₹1,600.85 apiece on BSE. New Delhi: Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following ...

Find out if Glenmark Pharmaceuticals Ltd (GLENMARK:XNSE) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of ...

Karin Wells is best known as a CBC radio documentary maker and is a three-time recipient of the Canadian Association of Journalists documentary award. She is also a lawyer and was inducted into the ...

PARENTS of a New Forest teenager who was killed by a faulty gas heater are angry that 10 years on “nothing has been done” to protect others. An inquest at Winchester this week heard how Tom Hill, from ...

A Bengaluru resident has converted a 1BHK rental apartment into a lush, green space. The tenant pays Rs 12,000 monthly for the Kasturi Nagar penthouse. It now houses over 500 plants, aquariums, and a ...

Stocks to Watch today: Adani Group stocks, United Breweries, HCL Tech, Glenmark Pharma, NTPC Green and Jindal Stainless are among the stocks to watch on Tuesday, June 3, 2025. Tuesday, June 03, 2025 | ...

Ichnos Glenmark Innovation's ISB 2001 has shown promising results in treating relapsed or refractory multiple myeloma (RRMM), demonstrating a 79% overall response rate in a Phase 1 study. The drug ...

Glenmark-Ichnos cancer drug shows 74% response in phase-1 trial The early-stage trial results signal promise for ISB 2001, a first-in-class trispecific antibody being developed for patients with ...

Glenmark Pharmaceuticals’ arm, Ichnos Glenmark Innovation (IGI), shared encouraging early results from a new cancer drug being tested on patients with a difficult form of blood cancer—relapsed or ...

Ichnos Glenmark Innovation (IGI), a biotechnology company focused on cancer treatments, has announced positive results from an early-stage global study of its investigational drug for patients with ...